去纤维钠的价格

(Defibrotide, defiteli) is a new drug used to treat hepatic veno-occlusive disease (HVOD) after hematopoietic stem cell transplantation (HSCT). The price of new drugs is usually an aspect that everyone is more concerned about. Defebriate sodium is not currently on the market in my country. The most cost-effective one in the world is about $22,000 per box. Patients can consult their medical companions for specific information.

Defibrotide (defiteli) is a single-stranded oligonucleotide mixture with anti-thrombotic and fibrinolytic effects. It has a good effect in preventing hepatic veno-occlusive disease (HVOD), one of the serious complications after hematopoietic stem cell transplantation (HSCT). It is favored by many patients and doctors internationally.

Defibrotide sodium (defiteli) has a relatively good therapeutic effect in both adults and children. The dose used in treatment should be based on the patient's weight. The recommended dose is 6.25 mg/kg given every 6 hours as a 2-hour intravenous infusion. Minimum usage time is 21 days. If signs and symptoms of HVOD have not resolved after 21 days, continue defibrination until resolution of HVOD or up to a maximum of 60 days.

Defibrinated sodium must be diluted prior to intravenous infusion. To avoid an increased risk of bleeding during treatment, concomitant use of defibrinated sodium with antithrombotic or fibrinolytic agents is contraindicated.

In a clinical trial on the treatment of HVOD in children, the complete response (CR) rate of using defibrotide (defiteli) was 76%, and the overall survival (OS) rate 1,00 days after transplantation was 64%. The effect is very significant.

(Defibrotide, defiteli) is currently not available in hospitals in my country. If patients want to know the specific price and purchase method of defibrinated sodium, they can consult the medical companion service, and we will sincerely serve you.